Bharat Biotech MD says Ideal time for COVID booster shot is six months after second dose
Taking the Covaxin vaccine by Prime Minister Narendra Modi showed confidence in Indian Science, he said during a summit
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Bharat Biotech
The Covaxin-WHO EUL saga
Manufacturers will need to cover all bases from the start, as the regulatory process will only get more stringent and competitive
WHO issues Emergency Use Listing for eighth COVID-19 vaccine
WHO’s EUL procedure assesses the quality, safety and efficacy of COVID-19 vaccines and is a prerequisite for COVAX vaccine supply
India ready to produce over five billion COVID vaccine doses by end of 2022: PM Modi
Prime Minister Modi expressed satisfaction over the G20's decision to come up with a 15 per minimum corporate tax to make the…
Review of Covaxin underway, expect a recommendation within 24 hours: WHO
The Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new…
India committed to supplying COVID-19 vaccines to other nations by year end
The country had suspended exports of COVID-19 vaccines in April to focus on inoculating its own population following a sudden…
WHO Chief discusses Covaxin and resumption of AstraZeneca vaccine supply to COVAX facility with…
COVID-19 Technology Access Pool (C-TAP) was launched in May last year for facilitating timely, equitable and affordable access of…
India resumes vaccine exports as domestic stocks build up: Officials
So far, about four million shots have been exported
Bharat Biotech awaits regulatory approvals to launch Covaxin for children
The SEC on COVID-19 examined the data and deliberated on the EUA application yesterday
Bharat Biotech submits clinical trial data of Covaxin in children to CDSCO
As part of the phase-II/III trial, the two-dose Covaxin was administered with 28 days apart.